Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/jpet.111.187062PMID 22028393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)

  2012influential reference
• Apical and basolateral pools of proteinase-activated receptor-2 direct distinct signaling events in the intestinal epithelium.

  2011cited by this paper
• Intestinal Cancer Risk in Crohn’s Disease: A Meta-Analysis

  2011cited by this paper
• Population‐based cases control study of inflammatory bowel disease risk factors

  2010cited by this paper
• Investigation of Possible Role of the PAR-2 Receptor in Intestinal Inflammation

  2010cited by this paper
• Serine proteases and protease‐activated receptor 2‐dependent allodynia: A novel cancer pain pathway

  2010cited by this paper
• Novel agonists and antagonists for human protease activated receptor 2.

  2010cited by this paper
• Protease‐activated receptors: novel central role in modulation of gastric functions

  2010cited by this paper
• Subjects with Diarrhea-Predominant IBS Have Increased Rectal Permeability Responsive to Tryptase

  2010influential reference
• German Cockroach Frass Proteases Modulate the Innate Immune Response via Activation of Protease-Activated Receptor-2

  2010cited by this paper
• Essential role for mast cell tryptase in acute experimental colitis

  2010cited by this paper
• Sensory Denervation Reduces Visceral Hypersensitivity in Adult Rats Exposed to Chronic Unpredictable Stress: Evidences of Neurogenic Inflammation

  2009cited by this paper
• Mesalamine Restores Angiogenic Balance in Experimental Ulcerative Colitis by Reducing Expression of Endostatin and Angiostatin: Novel Molecular Mechanism for Therapeutic Action of Mesalamine

  2009cited by this paper
• Surgery in Ulcerative Colitis: Indication and Timing

  2009cited by this paper
• Gastrointestinal roles for proteinase‐activated receptors in health and disease

  2008influential reference
• ELASTIC PROPERTIES OF RECRUITED LUNG TISSUE IN EXPERIMETAL ARDS: A CT SCAN STUDY

  2008cited by this paper
• Mucin Dynamics in Intestinal Bacterial Infection

  2008influential reference
• Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice

  2008influential reference
• Role of protease‐activated receptors in inflammatory responses, innate and adaptive immunity

  2008cited by this paper
• Evidence for the role of neurogenic inflammation components in trypsin‐elicited scratching behaviour in mice

  2008cited by this paper
• Serine proteases: new players in diarrhoea-predominant irritable bowel syndrome

  2008influential reference
• Curcumin reverses attenuated carbachol‐induced contraction of the colon in a rat model of colitis

  2008cited by this paper
• Protease-activated receptor-2 activation: a major actor in intestinal inflammation

  2008cited by this paper
• Colonic luminal proteases activate colonocyte proteinase‐activated receptor‐2 and regulate paracellular permeability in mice

  2007cited by this paper
• The Mast Cell-restricted Tryptase mMCP-6 Has a Critical Immunoprotective Role in Bacterial Infections*

  2007influential reference
• Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis.

  2007influential reference
• Therapeutic Promise of Proteinase-Activated Receptor-2 Antagonism in Joint Inflammation

  2006influential reference
• Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis

  2006cited by this paper
• Increased Potency of a Novel Complement Factor 5a Receptor Antagonist in a Rat Model of Inflammatory Bowel Disease

  2005cited by this paper
• A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis.

  2005influential reference
• Key role of mast cells and their major secretory products in inflammatory bowel disease.

  2004cited by this paper
• Modulation of tryptase secretion from human colon mast cells by histamine.

  2004influential reference
• Activation of human colon mast cells through proteinase activated receptor-2.

  2004influential reference
• Role of PAR2 in pain and inflammation.

  2002influential reference
• Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.

  2002influential reference
• Regulation of mucin secretion from in vitro cellular models.

  2002cited by this paper
• Effects of tumour necrosis factor-alpha synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis.

  2001cited by this paper
• Proteinase-Activated Receptors

  2001cited by this paper
• Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis

  2001influential reference
• Evaluation of the Substrate Specificity of Human Mast Cell Tryptase βI and Demonstration of Its Importance in Bacterial Infections of the Lung*

  2001influential reference
• Proteinase-activated receptors.

  2001cited by this paper
• Protease-activated receptors: sentries for inflammation?

  2000cited by this paper
• Protease-activated receptors mediate apamin-sensitive relaxation of mouse and guinea pig gastrointestinal smooth muscle.

  1999influential reference

• Protease-activated receptors act as a liaison between metabolism and inflammation.

  2026cites this paper
• A comprehensive review of small molecules, targets, and pathways in ulcerative colitis treatment.

  2025cites this paper
• Probing the activity of cysteine cathepsins in inflammatory bowel diseases

  2025cites this paper
• F2RL1 Inhibition Alleviates Lipotoxicity-Induced Kidney Injury Through the Hippo Pathway in Diabetic Kidney Disease

  2024cites this paper
• N‐terminomics profiling of naïve and inflamed murine colon reveals proteolytic signatures of legumain

  2024cites this paper
• Proteolytic bacteria expansion during colitis amplifies inflammation through cleavage of the external domain of PAR2

  2024cites this paper
• Protease-activated receptor 2 drives migration in a colon cancer cell line but not in non-cancerous human epithelial cells.

  2024cites this paper
• ADS024, a single-strain live biotherapeutic product of Bacillus velezensis alleviates dextran sulfate-mediated colitis in mice, protects human colonic epithelial cells against apoptosis, and maintains epithelial barrier function

  2024cites this paper
• Proteinase-activated Receptor 2: Springboard of Tumors

  2023cites this paper
• Effect of a protease-activated receptor-2 antagonist (GB88) on inflammation-related loss of alveolar bone in periodontal disease.

  2023cites this paper
• The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult

  2022cites this paper
• PARs in the inflammation-cancer transformation of CRC

  2022cites this paper
• Protease-activated receptor-2: Role in asthma pathogenesis and utility as a biomarker of disease severity

  2022cites this paper
• β‐Arrestin‐biased proteinase‐activated receptor‐2 antagonist C781 limits allergen‐induced airway hyperresponsiveness and inflammation

  2022cites this paper
• Antagonism of Protease Activated Receptor-2 by GB88 Reduces Inflammation Triggered by Protease Allergen Tyr-p3

  2021cites this paper
• Posttranslational modifications as therapeutic targets for intestinal disorders.

  2021cites this paper
• Protease-activated receptor-2 activation enhances epithelial wound healing via epidermal growth factor receptor

  2021cites this paper
• Expression of protease activated receptor-2 is reduced in renal cell carcinoma biopsies and cell lines

  2021cites this paper
• Molecular mechanisms regulating Proteinase‐Activated Receptors (PARs)

  2021cites this paper
• Pain pathways and potential new targets for pain relief

  2020cites this paper
• Activation of protease‐activated receptor 2 is associated with blood pressure regulation and proteinuria reduction in metabolic syndrome

  2020cites this paper
• Protease‐activated receptor‐2 accelerates intestinal tumor formation through activation of nuclear factor‐κB signaling and tumor angiogenesis in Apc Min/+ mice

  2020cites this paper
• Role of proteinase-activated receptors 1 and 2 in nonsteroidal anti-inflammatory drug enteropathy

  2020cites this paper
• Protease-Activated Receptor-2 Regulates Neuro-Epidermal Communication in Atopic Dermatitis

  2020cites this paper
• Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition

  2020cites this paper
• Blockage of protease-activated receptor 2 exacerbates inflammation in high-fat environment partly through autophagy inhibition.

  2020cites this paper
• Overexpression of tissue factor induced atherothrombosis in apolipoprotein E-/- mice via both enhanced plaque thrombogenicity and plaque instability.

  2019cites this paper
• Synthesis and Initial Pharmacology of Heterobivalent Ligands Targeting Putative Complexes of Integrin αVβ3 and PAR2

  2019cites this paper
• Activated clotting factor X mediates mitochondrial alterations and inflammatory responses via protease-activated receptor signaling in alveolar epithelial cells.

  2019cites this paper
• Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia

  2019cites this paper
• Pharmacological inhibition of protease‐activated receptor‐2 reduces crescent formation in rat nephrotoxic serum nephritis

  2019cites this paper
• Protease-activated receptor 2 exacerbates cisplatin-induced nephrotoxicity.

  2019cites this paper
• Protease-activated receptor 2 signaling modulates susceptibility of colonic epithelium to injury through stabilization of YAP in vivo

  2018cites this paper
• Bcl2L12 mediates effects of protease-activated receptor-2 on the pathogenesis of Th2-dominated responses of patients with ulcerative colitis.

  2018cites this paper
• Potent and Metabolically Stable Modified Peptide Agonists of Protease‐activated Receptor 2

  2018cites this paper
• Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer

  2018cites this paper
• Insulin decreases expression of the proinflammatory receptor proteinase-activated receptor-2 on human airway epithelial cells.

  2018cites this paper
• Shuganyin decoction improves the intestinal barrier function in a rat model of irritable bowel syndrome induced by water-avoidance stress

  2018cites this paper
• Therapeutic effect of protease-activated receptor 2 agonist SLIGRL-NH2 on loperamide-induced Sprague-Dawley rat constipation model and the related mechanism

  2018cites this paper
• A ROLE FOR BACTERIAL-DERIVED PROTEASES AND PROTEASE INHIBITORS IN FOOD SENSITIVITY.

  2017cites this paper
• Targeting coagulation factor receptors – protease‐activated receptors in idiopathic pulmonary fibrosis

  2017cites this paper
• Elevated fecal peptidase D at onset of colitis in Galphai2-/- mice, a mouse model of IBD

  2017cites this paper
• Proteinase-activated receptor 2 distribution and expression in equine small intestine tracts following herniation through the epiploic foramen.

  2017cites this paper
• Protease activated receptor 2 controls myelin development, resiliency and repair

  2017cites this paper
• Recombinant proteins of helminths with immunoregulatory properties and their possible therapeutic use.

  2017cites this paper
• Mapping transmembrane residues of proteinase activated receptor 2 (PAR2) that influence ligand‐modulated calcium signaling

  2017cites this paper
• Development of the gastrointestinal tract in young mammals : Effects of enteral provocation with protease or phytohaemagglutinin in neonatal rats

  2017cites this paper
• An HDAC6 Inhibitor Confers Protection and Selectively Inhibits B-Cell Infiltration in DSS-Induced Colitis in Mice

  2017influential citation
• Progression of Time-Dependent Changes to the Mechanisms of Vasodilation by Protease-Activated Receptor 2 in Metabolic Syndrome.

  2017cites this paper
• The Role of Protease-Activated Receptor-2 During Wound Healing in Intestinal Epithelial Cells

  2017cites this paper
• Inhibitory effect of FSLLRY-NH2 on inflammatory responses induced by hydrogen peroxide in HepG2 cells

  2017cites this paper
• 128338_Ester Arevalo Sureda

  2017cites this paper
• Pathophysiological roles of proteases in gastrointestinal disease.

  2016cites this paper
• Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity.

  2016cites this paper
• Protease activated receptor 2 (PAR2) modulators: a patent review (2010–2015)

  2016cites this paper
• Protease‐activated receptor 4: from structure to function and back again

  2016cites this paper
• PAR2 Modulators Derived from GB88.

  2016cites this paper
• Potent Small Agonists of Protease Activated Receptor 2.

  2016cites this paper
• Protease-Activated Receptor 2: Are Common Functions in Glial and Immune Cells Linked to Inflammation-Related CNS Disorders?

  2016cites this paper
• PAR2 regulates regeneration, transdifferentiation, and death

  2016cites this paper
• Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist

  2016cites this paper
• Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review

  2016cites this paper
• The TNBS-induced colitis animal model: An overview

  2016cites this paper
• Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease‐activated receptor‐2

  2016cites this paper
• A Chinese medicinal formulation ameliorates dextran sulfate sodium-induced experimental colitis by suppressing the activity of nuclear factor-kappaB signaling.

  2015cites this paper
• Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist Discovery

  2015cites this paper
• Potential novel targets: Protease-activated receptors in idiopathic pulmonary fibrosis

  2015cites this paper
• Presence of commensal house dust mite allergen in human gastrointestinal tract: a potential contributor to intestinal barrier dysfunction

  2015cites this paper
• Repurposing Registered Drugs as Antagonists for Protease-Activated Receptor 2

  2015cites this paper
• Protease-Activated Receptor-2 Up-Regulates Transient Receptor Potential Vanilloid 4 Function in Mouse Esophageal Keratinocyte

  2015cites this paper
• Increased production of BDNF in colonic epithelial cells induced by fecal supernatants from diarrheic IBS patients

  2015cites this paper
• Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists.

  2015cites this paper
• Trypsin-induced biphasic regulation of tone in the porcine lower esophageal sphincter.

  2015cites this paper
• Proteinase-activated receptor 2 : Are common functions in glial and immune cells linked to inflammation-related CNS disorders ?

  2015cites this paper
• Biased signalling and proteinase‐activated receptors (PARs): targeting inflammatory disease

  2014cites this paper
• Protease-Activated Receptors

  2014cites this paper
• Intestinal Protease-Activated Receptor-2 and Fecal Serine Protease Activity are Increased in Canine Inflammatory Bowel Disease and May Contribute to Intestinal Cytokine Expression

  2014cites this paper
• Evaluation on Potential Contributions of Protease Activated Receptors Related Mediators in Allergic Inflammation

  2014cites this paper
• Biased Signaling of Protease-Activated Receptors

  2014cites this paper
• Sensitisation of TRPV4 by PAR2 is independent of intracellular calcium signalling and can be mediated by the biased agonist neutrophil elastase

  2014influential citation
• Relationship between Mast Cells and Autoimmune

  2014cites this paper
• Pathway‐selective antagonism of proteinase activated receptor 2

  2014cites this paper
• Tumour progression and cancer-induced pain: a role for protease-activated receptor-2?

  2014cites this paper
• Tryptase‐PAR2 axis in experimental autoimmune prostatitis, a model for chronic pelvic pain syndrome

  2014cites this paper
• Activation of protease‐activated receptor‐2 disrupts vaginal epithelial barrier function

  2014cites this paper
• Relationship between Mast Cells and Autoimmune Diseases

  2014cites this paper
• Diet‐induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism

  2013cites this paper
• Low trypsinogen-1 expression in pediatric ulcerative colitis patients who undergo surgery.

  2013cites this paper
• PAR 2-induced inflammatory responses in human kidney tubular epithelial cells

  2013cites this paper
• Toward drugs for protease-activated receptor 2 (PAR2).

  2013cites this paper
• Diet-induced obesity , adipose inflammation , and metabolic dysfunction correlating with PAR 2 expression are attenuated by PAR 2 antagonism

  2013cites this paper
• Proteinase-activated receptors (PARs) – focus on receptor-receptor-interactions and their physiological and pathophysiological impact

  2013cites this paper
• PAR2-induced inflammatory responses in human kidney tubular epithelial cells.

  2013cites this paper
• Non-Systemic Drugs: A Critical Review

  2012cites this paper
• Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development.

  2012cites this paper
• An antagonist of human protease activated receptor‐2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen‐induced arthritis in rats

  2012cites this paper
• Targeting proteinase-activated receptors: therapeutic potential and challenges

  2012cites this paper
• Elafin in Intestinal Barrier Fortification: A Potential Adjuvant Therapy for Gluten Intolerance

  2012cites this paper
• Evaluation of antibodies directed against human protease-activated receptor-2

  2012cites this paper
• Lufaxin, a Novel Factor Xa Inhibitor From the Salivary Gland of the Sand Fly Lutzomyia longipalpis Blocks Protease-Activated Receptor 2 Activation and Inhibits Inflammation and Thrombosis In Vivo

  2012cites this paper